Cite
APA Citation
Colclough, N., Ballard, P., Barton, P., Chen, K., Cross, D., Finlay, M., Han, L., Janefeldt, A., Johnström, P., Ward, R., Wrigley, G., Yan, Y., Yates, J., Zhang, D., & Zhang, Z. (n.d.). preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs. European journal of cancer, 69, S28–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x000046